U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07425444) titled 'Attenuate the Stress Response in Laparoscopic Cholecystectomy' on Feb. 07.
Brief Summary: Aims of this study are to compare the effectiveness of dexmedetomidine versus fentanyl-midazolam in attenuating hemodynamic stress response during laparoscopic cholecystectomy (mainly HR). And to assess the recovery profile, the pain and opioid requirements, the sedation profile, and any adverse events during the first 24 hrs postoperatively
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Laparoscopic Cholecystectomy Surgery
Intervention:
DRUG: Dexmedetomidine
investigator will give Loading dose 1 mcg/kg IV over 10 min...